Literature DB >> 30922520

Pheochromocytoma: 20 years of improving surgical care.

Tarin C Worrest1, Erin W Gilbert1, Brett C Sheppard2.   

Abstract

BACKGROUND: Laparoscopic adrenalectomy is now the standard for pheochromocytoma. We report two decades of institutional experience with pheochromocytoma adrenalectomy.
METHODS: A retrospective review was undertaken of pheochromocytoma adrenalectomy patients between 1997 and 2017. Clinical variables and postoperative complications were recorded. Patients were divided into quartiles for analysis: group 1 from 1997 to 2001, group 2 from 2002 to 2006, group 3 from 2007 to 2011, and group 4 from 2012 to 2017.
RESULTS: Eighty-two pheochromocytoma adrenalectomies were identified. The percentage of laparoscopic adrenalectomies increased over time: 60% in group 1-87.5% in group 4 (p = 0.03). The average tumor size decreased: 6.4 cm (2.8-14.3 cm) in group 1-4.6 cm (1.2-7.8 cm) in group 4 (p = 0.03). ICU utilization decreased from 80% to 40.6% (p = 0.03) and length of stay decreased from 7.2 days to 2.7 days (p = 0.005). Clavien-Dindo grade>3 complications did not differ between the quartiles (p = 0.08).
CONCLUSION: Pheochromocytoma care has evolved from more open procedures with standard postoperative ICU stay to a laparoscopic resection with targeted ICU care and decreased length of stay. As experience with laparoscopic adrenalectomy increases, patient outcomes improve.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 30922520     DOI: 10.1016/j.amjsurg.2019.03.016

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  2 in total

1.  Pheochromocytoma of the prostate: An unusual location.

Authors:  Faten Hadj Kacem; Khouloud Boujelben; Wiem Feki; Khansa Chaabouni; Nadia Charfi; Mohamed Abid
Journal:  Urol Case Rep       Date:  2022-05-07

2.  Successful transurethral resection of the prostate in ectopic prostate pheochromocytoma: A case report.

Authors:  Jin Zhou; Wen-Feng Wu; Wenbin Zhang; Jun Xin; Wen-Hui Lei
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.